Adverse drug reactions (ADRs) are unwanted or harmful effects resulting from the use of medications at normal doses. They range from mild side effects to life-threatening conditions and represent a major concern in clinical practice. Understanding the mechanisms, risk factors, and prevention strategies for ADRs is essential to patient safety. ADRs can result from allergic responses, drug–drug interactions, or genetic predispositions. Research emphasizes predictive models, improved reporting systems, and early detection through biomarkers. Clinicians and regulatory authorities work together to minimize the risk and impact of ADRs.
sub tracks:
Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)
Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
